This page provides federal resources that are helpful during emergencies and disasters. We also created Medicaid & CHIP disaster preparedness toolkits to provide states and territories with additional disaster-related information.
Federal Disaster Resources
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Maryland for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Maryland’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Delaware for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Delaware’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Alabama for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Alabama’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Massachusetts for multiple section 1135 flexibilities on March 26, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Massachusetts’ response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Montana for multiple section 1135 flexibilities on March 30, 2020. Your follow-up communication to CMS on January 14, 2021, indicated Montana’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of Connecticut for multiple section 1135 flexibilities on March 27, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Connecticut’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Mexico for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 14, 2021 indicated New Mexico’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of New Hampshire for multiple section 1135 flexibilities on March 23, 2020 Your follow-up communication to CMS on January 12, 2021 indicated New Hampshire’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the State of North Carolina for multiple section 1135 flexibilities on March 23, 2020. Your follow-up communication to CMS on January 14, 2021 indicated North Carolina’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
The Centers for Medicare & Medicaid Services (CMS) granted an initial approval to the Commonwealth of Puerto Rico for multiple section 1135 flexibilities on April 14, 2020. Your follow-up communication to CMS on January 13, 2021 indicated Puerto Rico’s response to the COVID-19 pandemic has delayed its ability to submit a state plan amendment (SPA) to fulfill the requirements outlined in section 1006(b) of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (“SUPPORT Act”).
Show
entries